Co-diagnostics, inc. coprimers™ shown to be effective in covid-19 saliva pcr tests without sample extraction

Salt lake city, nov. 11, 2020 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that a recent company whitepaper demonstrates that the coprimer™ platform...
CODX Ratings Summary
CODX Quant Ranking